This inventor holds 1 USPTO granted patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Pan Li
Introduction
Pan Li is a notable inventor based in Zhejiang, China. He has made significant strides in the field of pharmaceuticals, particularly in developing compounds that address immune-related disorders. His work is characterized by a commitment to innovation and a focus on improving health outcomes.
Latest Patents
Pan Li holds a patent for a PD-L1 antagonist compound. This patent includes a compound of Formula (I) and a pharmaceutical composition thereof. The method outlined in his patent is designed to prevent and/or treat immune-related disorders, showcasing his dedication to advancing medical science.
Career Highlights
Pan Li is currently employed at Adlai Nortye Biopharma Co., Ltd. His role at the company allows him to leverage his expertise in pharmaceutical development. With a focus on innovative solutions, he has contributed to the company's mission of enhancing therapeutic options for patients.
Collaborations
Pan Li has collaborated with esteemed colleagues, including Zhiyong Yu and Beidi Xu. These partnerships reflect a collaborative spirit in the pursuit of groundbreaking research and development in the pharmaceutical industry.
Conclusion
Pan Li's contributions to the field of pharmaceuticals, particularly through his patent for a PD-L1 antagonist compound, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile